国际麻醉学与复苏杂志
國際痳醉學與複囌雜誌
국제마취학여복소잡지
INTERNATIONAL JOURNAL OF ANESTHESIOLOGY AND RESUSCITATION
2015年
3期
256-259
,共4页
瑞芬太尼%纤维支气管镜清醒气管插管%气道管理
瑞芬太尼%纖維支氣管鏡清醒氣管插管%氣道管理
서분태니%섬유지기관경청성기관삽관%기도관리
Remifentanil%Awake fibreoptic intubation%Airway management
背景 困难气道患者的围术期气道管理是临床麻醉关注的热点问题.纤维支气管镜清醒气管插管(awake fibreoptic intubation,AFO1)技术是处理预见性困难气道的公认方法.然而实施AFOI的难点在于给患者提供充分镇静、镇痛的同时,又要保证患者有效的自主通气功能.瑞芬太尼作为一种较理想的麻醉性镇痛药,一定剂量下能有效抑制气管插管的应激反应,故已有用于AFOI的报道. 目的 概述及评价瑞芬太尼在AFOI中的有效性及安全性,为临床应用和进一步研究提供参考. 内容 分析瑞芬太尼用于AFOI的剂量对机体的影响、不同给药方案的优劣以及在特殊患者中的应用. 趋向 瑞芬太尼在AFOI中的应用具有诸多优势,但最佳方案仍需进一步临床研究.
揹景 睏難氣道患者的圍術期氣道管理是臨床痳醉關註的熱點問題.纖維支氣管鏡清醒氣管插管(awake fibreoptic intubation,AFO1)技術是處理預見性睏難氣道的公認方法.然而實施AFOI的難點在于給患者提供充分鎮靜、鎮痛的同時,又要保證患者有效的自主通氣功能.瑞芬太尼作為一種較理想的痳醉性鎮痛藥,一定劑量下能有效抑製氣管插管的應激反應,故已有用于AFOI的報道. 目的 概述及評價瑞芬太尼在AFOI中的有效性及安全性,為臨床應用和進一步研究提供參攷. 內容 分析瑞芬太尼用于AFOI的劑量對機體的影響、不同給藥方案的優劣以及在特殊患者中的應用. 趨嚮 瑞芬太尼在AFOI中的應用具有諸多優勢,但最佳方案仍需進一步臨床研究.
배경 곤난기도환자적위술기기도관리시림상마취관주적열점문제.섬유지기관경청성기관삽관(awake fibreoptic intubation,AFO1)기술시처리예견성곤난기도적공인방법.연이실시AFOI적난점재우급환자제공충분진정、진통적동시,우요보증환자유효적자주통기공능.서분태니작위일충교이상적마취성진통약,일정제량하능유효억제기관삽관적응격반응,고이유용우AFOI적보도. 목적 개술급평개서분태니재AFOI중적유효성급안전성,위림상응용화진일보연구제공삼고. 내용 분석서분태니용우AFOI적제량대궤체적영향、불동급약방안적우렬이급재특수환자중적응용. 추향 서분태니재AFOI중적응용구유제다우세,단최가방안잉수진일보림상연구.
Background Perioperative airway management of patients with difficult airways is a hot issue in clinical anesthesia.Awake fibreoptic intubation (AFOI) is the standard management of the predicted difficult airway.However,it is not always easy to provide adequate sedation,analgesia for patients and ensure effective spontaneous ventilation at the same time.Certain doses of remifentanil can inhibit the stress response of intubation.As an ideal narcotic analgesics,it has been reported for AFOI.Objective To evaluation the efficacy and safety of remifentanil administration in the AFOI and provide evidence for its clinical application and further studies.Content The impact of different doses of remifentanil on the patients in AFOI,the advantages and disadvantages of different prescribes as well as its application in special patients were analyzed in this review.Trend Although remifentanil has been proved to possess many advantages in AFOI,the best dosage regimen still needs further clinical studies.